Gene Query: CARS

Dataset Description Geneva Score
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 126.22
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 88.96
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 88.96
RNA sequencing of GlyH-101-treated MCF-7 cell line 75.61
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 69.29
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 65.34
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 57.44
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 56.14
Cell responses to dysregulated VZV-induced cell-cell fusion 55.48
Human HAP1 cells before and after nutrient deprivation 53.94
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 53.94
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 51.08
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 50.51
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 49.47
ETV7 and interferon response 47.48
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 47.48
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 45.9
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 44.22
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 42.83
Zika infected neural stem cells 41.39
Transcriptome analysis of Zika infected neural stem cells 41.39
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 40.13
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 40.04
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 38.8
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 38.07
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 37.04
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 37.04
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 36.35
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 35.12
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 34.38
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 32.23
Effect of FGF13 depletion on the H460 cell line 31.58
Transcriptome analysis in Neobractatin treated cells 30.94
TCF7L1 knockdown in pancreatic cancer 30.72
MYCi361 regulates MYC target genes 30.02
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 29.99
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 29.88
RNAseq analysis of ESRP regulated splicing events in prostate cancer 29.83
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 29.22
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 29.14
Hepatitis C virus functionally sequesters miR-122 29.14
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 28.89
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 28.7
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 28.65
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 28.48
Gene expression analysis of dengue-infected cells 28.35
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 27.01
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 27.0
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 26.43
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 26.03
Biological effect of chronic mistranslation in mammalian cells 25.6
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 24.81
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 24.68
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 24.55
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 24.27
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 24.21
Tracking of dCas9-methyltransferase footprints 24.07
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 22.74
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 22.74
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 22.61
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 22.22
RNA-seq of IL-4 stimulated human keratinocytes 21.94
AUF-1 affected genes in human skin cells 21.88
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 21.84
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 21.83
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 21.83
Identifying the molecular mode of action of itraconazole in colorectal cancer 21.47
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 21.0
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 20.99
TGF-β regulation of miRNA expression in pancreatic cancer 20.9
Gene expression analysis of the impact of TDP-43 knockout in human cells. 20.82
IRF1 regulates IFN dependent and independent gene expression 20.76
Genome-wide analysis of Dengue virus 2 infected cells 20.52
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 20.5
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 20.45
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 20.01
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 20.01
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 19.83
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 19.79
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 19.79
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 19.55
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 19.52
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 19.49
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 19.46
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 19.28
Gene expression profiling of leukemia cells following asparagine depletion 19.03
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 18.82
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 18.68
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 18.68
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 18.23
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 18.05
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 17.99
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 17.75
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 17.74
The DPYSL2 gene connects mTOR and schizophrenia 17.63
Peptidomimetic blockade of MYB in acute myeloid leukemia 17.59
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 17.59
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 17.38
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 17.36
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 17.33
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 17.25
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 17.23
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 16.84
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 16.83
RNA-seq of RKO cells with cTAZ KO or putback 16.82
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 16.81
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 16.79
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 16.74
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 16.43
Genome-wide analysis of the Integrator complex 16.36
Genome-wide analysis of the Integrator complex (HTS) 16.36
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 16.32
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 16.25
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 16.16
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 16.14
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 16.1
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 16.05
RNA-seq analysis to identify the genes regulated by p53-SET interplay 15.91
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 15.45
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 15.41
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 15.18
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 15.12
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 15.04
Effect of Hotair overexpression in human breast cancer cell lines 15.0
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 14.96
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 14.94
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 14.85
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 14.79
Differential gene expression in Jagged1 treated human dental pulp cells. 14.63
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 14.45
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 14.42
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 14.39
Overexpression of NFIB and YBX1 in MCF-7 cells 14.37
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 14.37
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 14.36
RNAseq Study in CC-671 Treated Cal-51 Cells 14.25
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 14.1
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 14.07
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 14.05
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 13.82
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 13.81
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 13.75
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 13.47
Differential gene expression profiles in imatinib-resistant cell lines 13.45
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 13.41
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 13.41
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 13.39
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 13.36
RNA-seq analyisis of PUM2 knockout cells 13.3
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 13.3
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 13.28
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 13.17
In situ CAPTURE of chromatin interactions by biotinylated dCas9 13.17
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 13.15
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 13.03
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 12.96
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 12.95
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 12.81
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 12.81
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 12.81
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 12.76
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 12.76
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 12.75
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 12.74
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 12.67
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 12.65
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 12.65
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 12.63
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 12.6
MCF10A H-Ras RNA-Seq 12.57
FOXD3 is a novel tumor suppressor in lung cancer 12.57
RNA-Seq analysis of breast cancer cells after shikonin treatment 12.56
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 12.55
Identification of Sin3B regulated genes during quiescence 12.54
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 12.53
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 12.49
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 12.43
Transcriptome analysis of BAP1 knockout and restoration 12.42
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 12.42
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 12.34
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 12.34
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 12.32
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 12.32
RNA-seq analysis of uveal melanoma cells treated with FR900359 12.3
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 12.29
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 12.17
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 12.15
RNA-sequencing of human liver tissue 12.1
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 12.04
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 12.03
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 11.98
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 11.96
Neurofibroma 11.88
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 11.88
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 11.87
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 11.87
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 11.83
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 11.75
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 11.71
4sU-seq of HFF exposed to salt and heat stress 11.71
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 11.69
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 11.67
Expression profiling of etoposide-induced senescent cells 11.65
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 11.62
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 11.62
The circadian transcriptional landscape in primary human mammary epithelial cells 11.6
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 11.56
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 11.56
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 11.56
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 11.52
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 11.37
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 11.31
A Unique Epigenomic Landscape Defines Human Erythropoiesis 11.25
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 11.25
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 11.22
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 11.21
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 11.19
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 11.18
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 11.15
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 11.11
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 11.03
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 10.97
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 10.96
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.89
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.89
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 10.88
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 10.86
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 10.86
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 10.85
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 10.82
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 10.78
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 10.78
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 10.75
IMP3 regulated gene expression in breast cancer cells 10.73
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 10.68
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 10.67
Splicing and epigenetic factors jointly regulate epidermal differentiation 10.57
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 10.52
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 10.52
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 10.51
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 10.49
Differetially expressed genes after hTR overexpression in U2OS cells 10.48
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 10.44
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 10.4
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 10.4
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 10.38
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 10.38
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 10.38
The MEF2B Regulatory Network - RNA-seq data 10.36
The MEF2B Regulatory Network 10.36
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 10.35
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 10.32
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 10.32
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 10.29
Ro60-knockout cells 10.29
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 10.28
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 10.27
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 10.27
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 10.25
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 10.23
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 10.09
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 10.03
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 10.03
SETBP1-WT and SETBP1-G870S epigenetic landscapes 10.02
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 10.02
RNA transcriptome analysis during HSV-1 infection 10.02
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 9.99
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 9.99
Zika virus directly infects human peripheral neurons and induces cell death 9.99
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 9.98
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 9.95
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.95
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 9.95
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 9.91
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 9.91
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 9.89
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 9.87
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 9.87
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 9.86
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 9.86
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.78
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 9.74
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 9.71
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 9.71
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 9.68
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 9.64
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 9.61
Hijacking of stress response machinery by oncogenes in acute leukaemia 9.61
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 9.6
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 9.6
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 9.57
Regulation of Lipids is Central to Replicative Senescence 9.51
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 9.51
4sUDRB-seq: measuring transcription elongation and initiation genomewide 9.47
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 9.38
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 9.37
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 9.36
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 9.35
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 9.35
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 9.33
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 9.27
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 9.27
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 9.26
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.19
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 9.14
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 9.14
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 9.07
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 9.05
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 9.05
DAOY-Notch1/Notch2 knockout: transcriptome comparison 9.04
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 9.03
RNA Seq of HMVEC under hypoxia 9.03
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.89
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 8.89
Generation of KRAS signatures using immortalized isogenic lung cells. 8.88
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 8.81
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 8.7
HNRNPM-regulated splicing dependencies in prostate cancer 8.7
Selective expression of long non-coding RNAs in a breast cancer cell progression model 8.62
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 8.58
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 8.58
Fbxo32 mediated gene expression program underlies EMT and metastasis 8.54
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 8.53
Effect of BB608 on Gene Expression in HNSCC Cell Line 8.53
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 8.52
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 8.5
KSDM1b Role in Ewing Sarcoma 8.35
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 8.31
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 8.31
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 8.31
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 8.28
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 8.25
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.17
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 8.16
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 8.12
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 8.12
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 8.12
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 8.06
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 7.97
HBEC-shp53-PCHD7 7.93
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 7.86
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 7.82
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 7.82
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 7.76
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 7.65
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 7.57
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 7.57
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 7.56
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 7.46
Modeling Familial Cancer with iPSC Approaches 7.42
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 7.4
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 7.4
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 7.33
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 7.33
Comparative Analysis of Cas9 Activators Across Multiple Species 7.28
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 7.26
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 7.2
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 7.19
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 7.15
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 7.11
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 7.06
Knockdown of ADNP in HCT116 colon cancer cells 7.01
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 7.0
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 6.96
Recovery and analysis of nascent RNA 6.96
HEK293 Heat-shock experiment 6.92
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 6.76
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 6.71
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 6.71
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 6.6
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 6.56
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 6.54
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 6.45
RNA-seq of CD33 KO and control HSPCs 6.36
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 6.35
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 6.35
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 6.33
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 6.33
Primary Human B-cell Temporal Response to CD40L Stimulation 6.2
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 6.19
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 6.14
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 6.14
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 6.02
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.92
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.85
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.83
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 5.82
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 5.63
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 5.63
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.62
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 5.59
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.57
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.56
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 5.56
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 5.53
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 5.53
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.53
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 5.5
HEK293 TFAM Knockout Expression Study 5.3
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.21
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 5.15
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 5.14
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 5.14
High level DNA repair gene expression in human ES cells 5.14
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 5.07
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 4.86
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 4.77
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 4.7
ARID1A and ARID1B loss in HCT116 cells 4.55
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 4.54
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 4.33
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 4.33
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 4.24
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 4.24
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 4.19
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 4.12
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 4.05
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.01
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 3.97
ARID1A and ARID1B loss in HCT116 and TOV21G cells 3.96
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.9
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.73
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.72
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.71
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.67
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 3.59
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.55
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.43
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.42
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.39
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.31
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 3.28
Triple vectors expand AAV transfer capacity in the retina 3.16
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 2.98
Effect of nuclear IL-33 on gene expression 2.92
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.88
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.83
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 2.77
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.76
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.62
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.47
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 2.37
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 2.34
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.34
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.27
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 2.25
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.23
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.08
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.08
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.06
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.79
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 1.79
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.65
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 1.6
High-throughput sequencing of PROMPT-enriched samples. 1.53
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.53
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.53
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.52
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 1.51
Regulation of hypoxia-inducible factor activity by ZMYND8 1.5
Human Treg IFNg/IL-10 subpopulations 1.5
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.46
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.41
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 1.37
Effects of transcription on genome - nuclear lamina interactions 1.31
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.31
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 1.26
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 1.24
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 1.23
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.22
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.18
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.12
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.12
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.06
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.94
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.94
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.93
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.75
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.71
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.64
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.55
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.55
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.46
Targeting MTHFD2 in Acute Myeloid Leukemia 0.42
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.41
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.33
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.33
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.3
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.28
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.2
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.18
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.18
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.05
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.05
N6-methyladenine DNA Modification in Glioblastoma 0.04
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.04
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.03
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.01
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.01
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation